Pherecydes Pharma Successfully Completes €3.1 Million Capital Increase
Regulatory News: Not for release, either directly or indirectly, in the United States, Canada, Australia or Japan. Pherecydes Pharma (FR0011651694 ALPHE) (Paris:ALPHE), a biotechnology company